Search
Search Results
##search.searchResults.foundPlural##
-
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2077PDF: 1275HTML: 359 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2819PDF: 974HTML: 2150 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1595PDF: 842HTML: 594 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8030PDF: 2548HTML: 2185Table 1.: 292Table 2.: 318Table 3.: 277Table 4.: 282 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4531PDF: 1490HTML: 2219 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1992PDF: 2196Suppl. Files: 304HTML: 129 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4285PDF: 1372HTML: 2136Table 1: 260 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
811PDF: 517HTML: 6300 -
Severe Acute Hepatitis B Treated with Entecavir
1774PDF: 953HTML: 2576Figure: 228Title page: 234disclosure: 154 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1820PDF: 908HTML: 977cover letter: 393 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
902PDF: 609HTML: 4058 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1743PDF: 1002HTML: 419 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1507PDF: 998HTML: 1312fig 1A: 254figure1B: 220 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2563PDF: 1994HTML: 203 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
3057PDF: 1062HTML: 675 -
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5270PDF: 3051HTML: 2390 -
-
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3535PDF: 1002HTML: 1565Fig.1 CHL-R paper: 285Fig 2 CHL-R paper: 323 -
-
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1559PDF: 975HTML: 10136cover letter to the editor: 229tile page: 311 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1388PDF: 883HTML: 434 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1351PDF: 601HTML: 1730Figures: 226Fifures Sanz: 234tables Sanz: 239Untitled: 230 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6601PDF: 2290HTML: 14187Untitled: 273figure: 245 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
4068PDF: 1413HTML: 989Figure 2: 535Figure 1: 3224 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1665PDF: 938HTML: 1136Untitled: 237 -
MAGNUSIOMYCES CAPITATUS BREAKTHROUGH INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RECEIVING ECHINOCANDIN PROPHYLAXIS: CLINICAL FEATURES, MANAGEMENT, AND REVIEW OF THE LITERATURE
225PDF: 258Suppl. Files: 51Html: 123Html Suppl. Files: 110 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3126PDF: 1487HTML: 3750Untitled: 284Untitled: 280Untitled: 231 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
998PDF: 858HTML: 259 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1690PDF: 1006Suppl. Files: 505HTML: 316







